Inmune Bio Inc (INMB)
$1.45 -9.38% Close Oct 30, 2026 Live
Inmune Bio stock today
Inmune Bio closed at $1.45 on October 30, 2026, down 9.38% on the day. Over the past year it returned -16.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $39.0 million.
$1.50$2.00$2.50
NovJan 2026MarMayJulSep
| Period | INMB | S&P 500 (SPY) |
|---|---|---|
| 1 month | -25.6% | -0.9% |
| 3 months | -18.1% | +2.1% |
| Year to date | -7.1% | +11.7% |
| 1 year | -16.2% | +12.4% |
| 3 years | -78.6% | +88.5% |
| 5 years | -92.1% | +76.0% |
Key statistics
- Market value
- $39.0M
- 52-week range
- $1.12 to $2.51
- Next report
- Nov 5, 2026
About Inmune Bio
Develops immunotherapies for cancer and infectious diseases.
Sector: Health Care
More on Inmune Bio
- Financials: revenue, earnings and segmentsRevenue +257% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $78.85 today
No forecast, no recommendation. This page describes Inmune Bio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.